Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#3618 Biliary neuroendocrine neoplasms – Experience of an Algerian center
Introduction: Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors, biliary NENs are accounting for only 2% of the GEP-NENs. Due to the rarity of these neoplasms, there is a lack of information in their epidemiology, clinicopathological features, treatment and their prognosis.
Conference:
Presenting Author: Belabdi D
Authors: Belabdi D, Chouki S, Bouferroum L, Noubli A, Oukkal M,
Keywords: Neuroendocrine neoplasm, Biliary tract NENs, Rare tumor,
Introduction: Since the results of the CLARINET study, somatostatin analogues (SSAs) have an important place in the anti-proliferative treatment of well-differentiated neuroendocrine tumors (w-d NETs) grade 1 and 2 Ki-67
Conference:
Presenting Author: Belabdi D
Authors: Belabdi D, Chouki S, Yala I, Oukkal M,
Keywords: Well-differentiated NET, Grade 2 Ki-67≥10%, Somatostatin Analogues, Anti-proliferative treatment,
Introduction: Neuroendocrine Noplasms (NEN) are rare tumours, but their incidence is clearly increasing in our country due to the improvement of diagnostic means, in particular the generalization of immunohistochemical techniques. The digestive location represents more than 70% of the cases. The anatomopathological study enables to classify the NEN in different prognostic grades according to the degree of differentiation, mitotic index and Ki67.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Belabdi D
Authors: Belabdi D, Mekarnia A, Ouzit S, Ainouche A, Oukkal M,
Keywords: Digestive neuroendocrine neoplasm, immunohistochemical profil, WHO classification 2017,
#1752 Neuroendocrine Tumors: A Retrospective Analysis in a Single Algerien Institution
Introduction: Neuroendocrine tumors (NETs) are heteregenous group of tumors.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Djihed B, Alyda M, Mohammed O,
Keywords: Neuroendocrine tumors,
Introduction: Sunitinib is indicated in the treatment of patients with advanced progressive pancreatic neuroendocrine tumors (pNETs).Its experience as first line therapy is limited.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Djihed B, Alyda M, Mohammed O,
Keywords: pNETs,SUNITINIB ,first line.,